Rebecca A. Haberman, Ph.D.
Affiliations: | 2001 | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
Neuroscience Biology, GeneticsGoogle:
"Rebecca Haberman"Mean distance: 42746.4
Parents
Sign in to add mentor| Thomas McCown | grad student | 2001 | UNC Chapel Hill | |
| (Regulation of recombinant adeno -associated virus vector derived gene expression and functional analysis in a focal seizure genesis model.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gray SJ, Choi VW, Asokan A, et al. (2011) Production of recombinant adeno-associated viral vectors and use in in vitro and in vivo administration. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 4.17 |
| Choi VW, Asokan A, Haberman RA, et al. (2007) Production of recombinant adeno-associated viral vectors. Current Protocols in Human Genetics / Editorial Board, Jonathan L. Haines ... [Et Al.]. Unit 12.9 |
| Choi VW, Asokan A, Haberman RA, et al. (2007) Production of recombinant adeno-associated viral vectors for in vitro and in vivo use. Current Protocols in Molecular Biology / Edited by Frederick M. Ausubel ... [Et Al.]. Unit 16.25 |
| Choi VW, Asokan A, Haberman RA, et al. (2006) Production of recombinant adeno-associated viral vectors and use for in vitro and in vivo administration. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 4.17 |
| Haberman R, Criswell H, Snowdy S, et al. (2002) Therapeutic liabilities of in vivo viral vector tropism: adeno-associated virus vectors, NMDAR1 antisense, and focal seizure sensitivity. Molecular Therapy : the Journal of the American Society of Gene Therapy. 6: 495-500 |
| Haberman RA, Kroner‐Lux G, Samulski RJ. (1999) Production of Recombinant Adeno‐Associated Viral Vectors Current Protocols in Human Genetics. 23 |